Eagle Pharmaceuticals
EGRX
#10440
Rank
C$6.17 M
Marketcap
C$0.48
Share price
0.00%
Change (1 day)
-59.53%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: C$6.17 Million

As of February 2026 Eagle Pharmaceuticals has a market cap of C$6.17 Million. This makes Eagle Pharmaceuticals the world's 10440th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026C$6.17 M-22.69%
2025C$7.98 M-21.92%
2024C$10.22 M-88.65%
2023C$90.08 M-82.55%
2022C$0.51 B-38.4%
2021C$0.83 B8.31%
2020C$0.77 B-27.66%
2019C$1.06 B40.06%
2018C$0.76 B-23.8%
2017C$1.00 B-39.26%
2016C$1.65 B-14.21%
2015C$1.92 B661.76%
2014C$0.25 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
C$6.17 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
C$745.32 B 12,071,930.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$388.35 B 6,290,134.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
C$1.265 T 20,500,064.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$250.60 B 4,059,004.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$152.55 B 2,470,877.76%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$141.96 B 2,299,288.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
C$53.22 B 861,997.57%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel